Last news
Fapon to Showcase Innovative Molecular Diagnostic Solutions at AMP 2025 Annual Meeting & Expo

Fapon to Showcase Innovative Molecular Diagnostic Solutions at AMP 2025 Annual Meeting & Expo

BOSTON, Nov. 10, 2025 /PRNewswire/ -- Fapon, a globally leading life sciences organization, will exhibit at the AMP 2025 Annual Meeting & Expo during November 11-15 in Boston, presenting its cutting-edge enzymes for molecular diagnostics that...

Simcere's IL-2 Mutant Fusion Protein SIM0278 Entered Phase II Clinical Trial Stage

Simcere's IL-2 Mutant Fusion Protein SIM0278 Entered Phase II Clinical Trial Stage

NANJING, China, Nov. 10, 2025 /PRNewswire/ -- Simcere Pharmaceutical Group (2096.HK) announced that its regulatory T cells(Treg)-preferential IL-2 mutant Fc fusion protein (IL-2 mu-Fc), SIM0278, has officially entered a Phase II clinical study in...

Origin Agritech Strengthens Gene Editing Platform through Patent License Agreement with Shunfeng BioTech

Origin Agritech Strengthens Gene Editing Platform through Patent License Agreement with Shunfeng BioTech

BEIJING, Nov. 10, 2025 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), a leading Chinese agricultural technology company, today announced it has entered into a patent license agreement with Shandong Shunfeng...

LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)

LISCure Biosciences Initiates Global Phase 2 Trial of LB-P8 in Primary Sclerosing Cholangitis (PSC)

SEOUL, South Korea, Nov. 10, 2025 /PRNewswire/ -- LISCure Biosciences ("LISCure"), a clinical-stage biopharmaceutical company, announced the initiation of patient dosing in a global Phase 2 clinical trial of LB-P8, a novel therapeutic candidate for...

Akeso Announces First Patient Dosed in Phase I Trial of Personalized mRNA Vaccine AK154 as Monotherapy or in Combination with Cadonilimab or Ivonescimab for Adjuvant Treatment of Pancreatic Cancer

Akeso Announces First Patient Dosed in Phase I Trial of Personalized mRNA Vaccine AK154 as Monotherapy or in Combination with Cadonilimab or Ivonescimab for Adjuvant Treatment of Pancreatic Cancer

HONG KONG, Nov. 10, 2025 /PRNewswire/ -- Akeso, Inc. (HKEX: 9926. HK) is pleased to announce that the first patient has been dosed in a Phase I clinical trial evaluating the personalized mRNA vaccine AK154. This trial is investigating AK154 both as...

DFRobot UNIHIKER K10 Crowned Winner in Teach Secondary's EdTech & Software Category at 2025 TeachCo Resource Awards

DFRobot UNIHIKER K10 Crowned Winner in Teach Secondary's EdTech & Software Category at 2025 TeachCo Resource Awards

SHANGHAI, Nov. 10, 2025 /PRNewswire/ -- DFRobot is proud to announce that its UNIHIKER K10 has received the top honor in the "Teach Secondary's EdTech & Software" category at the prestigious 2025 TeachCo Resource Awards. DFRobot UNIHIKER K10...

CNFINANCE TO HOLD AN EXTRAORDINARY GENERAL MEETING ON DECEMBER 10, 2025

CNFINANCE TO HOLD AN EXTRAORDINARY GENERAL MEETING ON DECEMBER 10, 2025

GUANGZHOU, China, Nov. 10, 2025 /PRNewswire/ -- CNFinance Holdings Limited (NYSE: CNF) ("CNFinance" or the "Company"), a leading home equity loan service provider in China, today announced that it will hold an Extraordinary General Meeting of...

Bybit Adds Polkadot (DOT) to On-Chain Earn

Bybit Adds Polkadot (DOT) to On-Chain Earn

DUBAI, UAE, Nov. 10, 2025 /PRNewswire/ -- Bybit, the world's second-largest cryptocurrency exchange by trading volume, is thrilled to announce that its On-Chain Earn platform has recently added support for Polkadot (DOT) staking. This new addition...

menu
menu